drugset / Trial / NCT02175121
Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Study Of PF-06291874 As Oral Monotherapy To Treat Adults With Type 2 Diabetes Mellitus
RandomizedParallel-groupDouble-blindTreatment
Summary
This study is going to assess the safety and tolerability of PF-06291874 in adults with Type 2 Diabetes Mellitus as monotherapy, to evaluate the significance of overall glycemic control in these subjects.
Timeline
- Start
- 2014-08
- Primary completion
- 2015-03
- Completion
- 2015-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PF-06291874 | Small molecule | 15 mg | Oral |
| Subject | PF-06291874 | Small molecule | 35 mg | Oral |
| Subject | PF-06291874 | Small molecule | 75 mg | Oral |
| Subject | PF-06291874 | Small molecule | 150 mg | Oral |